Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2011
04/06/2011EP2305291A1 Use of proteasome inhibitors for the treatment of HIV infections
04/06/2011EP2305286A2 Treatment for Alzeimer's disease
04/06/2011EP2305282A2 Prevention and treatment of amyloidogenic disease
04/06/2011EP2305281A1 Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep
04/06/2011EP2305276A2 Processed lipoaspirate cells for use in therapy
04/06/2011EP2305274A1 Use of WNT stimulators for treating demyelinating diseases
04/06/2011EP2305264A1 Spicamycin derivatives for use in decreasing or preventing pain
04/06/2011EP2305262A1 Selective PDE9A inhibitors as medicaments for the improvement of cognitive processes
04/06/2011EP2305260A1 Psychotropic agent and health food containing benzylisoquinoline derivative
04/06/2011EP2305258A2 Inhibition of neuronal damage
04/06/2011EP2305253A1 Use of pramipexole to treat amyotrophic lateral sclerosis
04/06/2011EP2305252A1 Use of pramipexole to treat amyotrophic lateral sclerosis
04/06/2011EP2305251A2 Pharmaceutical compositions comprising clavulanic acid or derivative thereof for the treatment of sexual disorder
04/06/2011EP2305248A1 Substituted phenethylsulfones and method of reducing tnf-alpha levels
04/06/2011EP2305230A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
04/06/2011EP2305229A1 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
04/06/2011EP2305225A1 Use of (1S, 2R) enantiomer of milnacipran for the preparation of a medicine
04/06/2011EP2305218A1 Controlled release hydrocodone formulations
04/06/2011EP2305213A2 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
04/06/2011EP2305194A1 Sustained analgesia achieved with buprenorphine
04/06/2011EP2305193A1 Sustained analgesia achieved with buprenorphine
04/06/2011EP2305192A1 Sustained analgesia achieved with buprenorphine
04/06/2011EP2305191A1 Sustained analgesia achieved with buprenorphine
04/06/2011EP2303926A1 Immunogenic memapsin 2 -secretase peptides and methods of use
04/06/2011EP2303895A1 Thiazolyl- and oxazolyl-isoquinolinones and methods for using them
04/06/2011EP2303884A1 Adenine receptor ligands
04/06/2011EP2303872A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators
04/06/2011EP2303871A1 Pyrrolidin-3-ylmethyl-amine as orexin antagonists
04/06/2011EP2303867A1 Pyrazinone modulator of corticotropin-releasing factor receptor activity
04/06/2011EP2303863A1 5- and 6-membered heterocyclic compounds
04/06/2011EP2303857A1 Cyclic sulfones with aminobenzyl substitution useful as bace inhibitors
04/06/2011EP2303853A2 Novel salts and polymorphs of desazadesferrithiocin polyether analogues as metal chelation agents
04/06/2011EP2303851A1 Novel phenolic and catecholic amines and prodrugs thereof
04/06/2011EP2303846A1 Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
04/06/2011EP2303845A2 Bi-and polycyclic substituted isoquinoline and isoquinoline derivatives as rho kinase inhibitors
04/06/2011EP2303407A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
04/06/2011EP2303392A1 Pharmacokinetics of iontophoretic sumatriptan administration
04/06/2011EP2303330A1 Pharmaceutical compositions for treatment of parkinson's disease
04/06/2011EP2303325A2 Inhibition of emmprin to treat multiple sclerosis
04/06/2011EP2303315A1 Method for treating disease characterized by plaque
04/06/2011EP2303311A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
04/06/2011EP2303309A2 Treatment of mitochondrial diseases with an erythropoietin mimetic
04/06/2011EP2303284A2 Methods of treatment of bipolar disorder
04/06/2011EP2303272A1 Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder
04/06/2011EP2303263A1 Use
04/06/2011EP2303261A1 Use of cyclolignans for the treatment of a hyperactive immune system
04/06/2011EP2094675B1 A salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one
04/06/2011EP1828151B1 Malonamide derivatives as inhibitors of gamma-secretase for the treatment of alzheimer's disease
04/06/2011EP1814849B1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
04/06/2011EP1685832B1 Nerve regeneration promoters
04/06/2011EP1628968B1 4-imidazolin-2-one compounds
04/06/2011EP1558259B1 Urea derivatives as IL-8 receptor antagonists
04/06/2011EP1519939B9 N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
04/06/2011EP1404324B2 Prodrugs of gaba analogs, compositions and uses thereof
04/06/2011EP1328236B1 Methods of decreasing or preventing pain using spicamycin derivatives
04/06/2011EP1303522B1 Biologically active macrolides, compositions, and uses thereof
04/06/2011EP1255556B1 Neuroprotective, antithrombotic and anti-inflammatory uses of activated protein c (apc)
04/06/2011CN201782997U Novel vehicle-mounted air purifier
04/06/2011CN201782427U Novel healthcare pillow
04/06/2011CN1812980B Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics
04/06/2011CN1762495B Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process
04/06/2011CN1658893B G-type peptides to ameliorate atherosclerosis
04/06/2011CN1376146B Solid-state form of celecoxil having enhanced bioavailability
04/06/2011CN102007133A 3-phenylpyrazolo[5,1-b]thiazole compounds
04/06/2011CN102007129A Derivatives of galantamine as pro-drugs for the treatment of human brain diseases
04/06/2011CN102007121A 1,5-diphenyl-pyrrolidin-2-one compounds as cb-1 ligands
04/06/2011CN102007117A Tertiary amine derivatives as phosphodiesterase-4 inhibitors
04/06/2011CN102007102A Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
04/06/2011CN102006882A Treating neurodegenerative diseases with progranulin (pgrn)
04/06/2011CN102002493A Application of small RNA-326 in preparation of medicament
04/06/2011CN102002441A Plant balm for improving physical and mental harmonious degree and preparation method thereof
04/06/2011CN102002104A Anti-VEGF monoclonal antibody and medicinal composition containing same
04/06/2011CN102002052A Ginkgolides K and compound thereof as well as preparation method and use thereof
04/06/2011CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof
04/06/2011CN102002049A Antigen and preparation method and application thereof
04/06/2011CN102001959A Medicinal crystal as well as preparation method and application thereof
04/06/2011CN102000345A Complex folic acid/beta-cyclodextrin composite and preparation method thereof
04/06/2011CN102000336A Carbostyril derivatives and mood stabilizers for treating mood disorders
04/06/2011CN102000334A Compound preparation for treating depression
04/06/2011CN102000318A Pharmaceutical composition for treating facial paralysis and preparation method thereof
04/06/2011CN102000315A Traditional Chinese medicinal composition for treating dizziness and preparation method thereof
04/06/2011CN102000314A Detection method of Chinese medicine composition for treating dizziness
04/06/2011CN102000298A Medicament for treating headache during menstruation
04/06/2011CN102000288A Traditional Chinese medicine for treating neurasthenia and insomnia
04/06/2011CN102000286A Traditional Chinese medicine preparation for treating polyneuritis
04/06/2011CN102000275A Medicinal composition for treating children with tic disorders and preparation method thereof
04/06/2011CN102000274A Sugar-free fire clearing Chinese herbal granules and preparation method thereof
04/06/2011CN102000266A Medicament for treating cardiovascular and cerebrovascular diseases and brain paralysis and preparation method thereof
04/06/2011CN102000264A Composition for treating climacteric syndrome as well as preparation method and detection method thereof
04/06/2011CN102000226A Medicine for treating hemiplegy
04/06/2011CN102000225A Health care medicament for sobering, removing alcoholism and preventing and treating fatty liver and preparation method thereof
04/06/2011CN102000223A Traditional Chinese medicine compound preparation for treating vascular dementia as well as preparation method and application thereof
04/06/2011CN102000212A Method for preparing composite earthworm health-care product
04/06/2011CN102000211A Traditional Chinese medicine composition for improving sleep and treating impotence and premature ejaculation, and preparation method thereof
04/06/2011CN102000193A Traditional Chinese medicine for treating insomnia
04/06/2011CN102000186A Quick-acting drug abstinence de-addiction pure Chinese medicinal preparation and preparation method thereof
04/06/2011CN102000184A Method for extracting substances for relieving alcoholism from honey trees
04/06/2011CN102000152A Preparation method for composite gingkgo health product
04/06/2011CN102000150A External liniment for treating facial neuritis
04/06/2011CN102000148A Application of scutelaria baicalemis and baicalin in preparing medicament for improving learning memory and treating Alzheimer's disease